4
Changes in Ownership
TENAX THERAPEUTICS, INC. Filed Acc 0000899243-22-018968
Options or other derivatives
- Director acquired 38,181,790 shares (grant or award)
- Director returned 16,989,736 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table II: Derivative
12 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-18 | Returned to the company : show line 1 in the form Warrant (right to buy) | −4,773,269 | 0 | I |
| 2022-05-18 | Grant or award : show line 2 in the form Warrant (right to buy) | +4,773,269 | 4,773,269 | I |
| 2022-05-18 | Returned to the company : show line 3 in the form Series B Common Stock Purchase Warrants | −3,175,924 | 0 | I |
| 2022-05-18 | Grant or award : show line 4 in the form Series B Common Stock Purchase Warrants | +3,175,924 | 3,175,924 | I |
| 2022-05-18 | Returned to the company : show line 5 in the form Series C Common Stock Purchase Warrants | −4,607,692 | 0 | I |
| 2022-05-18 | Grant or award : show line 6 in the form Series C Common Stock Purchase Warrants | +4,607,692 | 4,607,692 | I |
| 2022-05-18 | Returned to the company : show line 7 in the form Common Stock Purchase Warrants | −2,360,313 | 0 | I |
| 2022-05-18 | Grant or award : show line 8 in the form Common Stock Purchase Warrants | +2,360,313 | 2,360,313 | I |
Loading xslF345X03/doc4.xml…